BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1166830)

  • 1. Iron metabolism in porphyria cutanea tarda.
    Reizenstein P; Höglund S; Landegren J; Carlmark B; Forsberg K
    Acta Med Scand; 1975; 198(1-2):95-9. PubMed ID: 1166830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY.
    KOVAL A; DANBY CW; PETERMANN H
    Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron metabolism and its responses to allopurinol treatment in porphyria cutanea tarda.
    Burger T; Horváth T; Jávor T
    Acta Med Acad Sci Hung; 1978; 35(2):115-27. PubMed ID: 742338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phlebotomy treatment of porphyria cutanea tarda.
    Lundvall O
    Acta Derm Venereol Suppl (Stockh); 1982; 100():107-18. PubMed ID: 6962627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phlebotomy on urinary porphyrin pattern and liver histology in patients with porphyria cutanea tarda.
    Di Padova C; Marchesi L; Cainelli T; Gori G; Podenzani SA; Rovagnati P; Rizzardini M; Cantoni L
    Am J Med Sci; 1983; 285(1):2-12. PubMed ID: 6824014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of porphyria cutanea tarda with and without phlebotomy (author's transl)].
    Leonhardi G; Klähn KH; Gürenci J
    MMW Munch Med Wochenschr; 1977 Jan; 119(2):43-6. PubMed ID: 401939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phlebotomy and iron-overload in porphyria cutanea tarda.
    Kalivas JT; Pathak MA; Fitzpatrick TB
    Lancet; 1969 Jun; 1(7607):1184-7. PubMed ID: 4181840
    [No Abstract]   [Full Text] [Related]  

  • 9. Porphyria cutanea tarda: clinical and laboratory features.
    Sweeney GD; Jones KG
    Can Med Assoc J; 1979 Apr; 120(7):803-7. PubMed ID: 427687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five cases of porphyria cutanea tarda with mild cutaneous changes: evaluation of the efficacy of phlebotomy by the pattern analysis of urinary porphyrins.
    Nonaka S; Ohgami T; Murayama F; Yamashita K; Yoshida H
    J Dermatol; 1986 Jun; 13(3):196-202. PubMed ID: 3537046
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of iron in experimental porphyria and porphyria cutanea tarda.
    Siersema PD; van Helvoirt RP; Cleton-Soeteman MI; de Bruijn WC; Wilson JH; van Eijk HG
    Biol Trace Elem Res; 1992 Oct; 35(1):65-72. PubMed ID: 1384628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron and hepatic uroporphyrin synthesis. Relation in porphyria cutanea tarda.
    Felsher BF; Jones ML; Redeker AG
    JAMA; 1973 Nov; 226(6):663-5. PubMed ID: 4800611
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda.
    Rocchi E; Gibertini P; Cassanelli M; Pietrangelo A; Borghi A; Ventura E
    J Lab Clin Med; 1986 Jan; 107(1):36-42. PubMed ID: 3941293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda.
    Lundvall O; Weinfeld A
    Acta Med Scand; 1968 Sep; 184(3):191-9. PubMed ID: 5703974
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda in association with hemosiderosis of the liver. Iron absorption studies and evaluation of therapy by phlebotomy.
    Strickland GT
    Am J Gastroenterol; 1968 Sep; 50(3):202-7. PubMed ID: 5677557
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of replenishment of iron stores after phlebotomy therapy in porphyria cutanea tarda.
    Lundvall O
    Acta Med Scand; 1971; 189(1-2):51-63. PubMed ID: 5166124
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intestinal absorption of iron observed in 2 cases of porphyria cutanea tarda].
    Cupella F; Pozzi U; Carena M; Schiavi A; Colombi R
    G Ital Med Lav; 1984; 6(5-6):259-60. PubMed ID: 6545217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Porphyrin metabolic disorders in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1989; (8):67-71. PubMed ID: 2816038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative liver function tests in porphyria cutanea tarda: improvement under therapeutic phlebotomy].
    Meister F; Reichen J
    Schweiz Med Wochenschr; 1986 Mar; 116(11):341-5. PubMed ID: 3961453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.